2002
DOI: 10.1155/2002/631070
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory Effects of Polaprezine on the Inflammatory Response toHelicobacter pylori

Abstract: Helicobacter pylori-infected gastrointestinal mucosa is frequently infiltrated by polymorphonuclear leukocytes (PMN) and monocytes, and these invading cells have been implicated in gastrointestinal mucosal inflammation. To clarify the efficacy of polaprezinc, a chelate compound consisting of zinc and L-carnosine, against H pylori-induced inflammation including PMN infiltration, the in vitro effects of this drug on interleukin (IL)-8 production by an established gastric cancer cell line (MKN 45 cells) and on PM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 24 publications
0
15
0
Order By: Relevance
“…Because PZ has been shown to exhibit potent ROSquenching effects [11,12], we employed PZ, a gastric muco-protective drug, as a candidate drug for the prevention of indomethacin-induced small intestinal mucosal damage. Besides its ROS-quenching effect, PZ has various other pharmacological actions, such as induction of the expression of heat shock protein 27 (HSP-27), HSP-72 [39], and heme oxygenase-1 (HO-1) [40], molecules which exhibit cytoprotective effects or an anti-inflammatory effect via the inhibition of adhesion molecules on polymorphonuclear leukocytes or the inhibition of cytokine production by gastric epithelial cells [41]. In the present study, we found that PZ significantly inhibited the indomethacin-induced apoptosis of RIE-1 cells (Figs.…”
Section: Discussionmentioning
confidence: 99%
“…Because PZ has been shown to exhibit potent ROSquenching effects [11,12], we employed PZ, a gastric muco-protective drug, as a candidate drug for the prevention of indomethacin-induced small intestinal mucosal damage. Besides its ROS-quenching effect, PZ has various other pharmacological actions, such as induction of the expression of heat shock protein 27 (HSP-27), HSP-72 [39], and heme oxygenase-1 (HO-1) [40], molecules which exhibit cytoprotective effects or an anti-inflammatory effect via the inhibition of adhesion molecules on polymorphonuclear leukocytes or the inhibition of cytokine production by gastric epithelial cells [41]. In the present study, we found that PZ significantly inhibited the indomethacin-induced apoptosis of RIE-1 cells (Figs.…”
Section: Discussionmentioning
confidence: 99%
“…In Japan, polaprezinc is commonly used for the treatment of gastric ulcer. Polaprezinc is a chelate compound consisting of zinc and L-carnosine that is thought to function in protecting intercellular tight junctions [11,12], as an anti-oxidant [13], in preventing apoptosis [14-16], and in reducing inflammation [17]. Omatsu et al [14] speculated that polaprezinc protects rat intestinal epithelial (RIE-1) cells from indomethacin-induced apoptosis via its reactive oxygen species (ROS)-quenching effect.…”
Section: Introductionmentioning
confidence: 99%
“…(20) Consequently, several studies have indicated that PZ can protect gastric mucosa against various stimuli in vivo (21,22) and in vitro . (15,23) In this study, we examined whether PZ can protect small intestinal epithelial cells from ASA-induced apoptosis, and determined the involvement of HSP70, induced by PZ, in this process.…”
Section: Introductionmentioning
confidence: 99%